Home・Listă Acțiuni・Haemonetics Corp

Haemonetics Corp

Deschisă

SectorSănătate

107.87 -0.39

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

106.69

Maxim

108.62

Indicatori cheie
By Trading Economics
Venit	53M 33M
Vânzări	-7M 339M
P/E Medie Sector	43.82 57.371
EPS	1.14
Marjă de profit	9.727
Angajați	3,009
EBITDA	70M 75M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	-5.55% downside

Dividende
By Acuity
Următoarele câștiguri	5 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	163M 4.1B
Deschiderea anterioară	108.26
Închiderea anterioară	107.87

Sentimentul știrilor

By Acuity

100%

326 / 340 Clasament în Healthcare

Haemonetics Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 aug. 2026, 19:46 UTC

Haemonetics Corp shares are lower today amid rising oil prices and geopolitical tensions. The stock rebounded earlier but has since declined in routine fluctuations.

21 aug. 2026, 23:01 UTC

Haemonetics Corp is modestly higher in after-market trading, maintaining strength above its 20-day moving average and nearing the upper end of its one-month range.

20 aug. 2026, 23:01 UTC

Haemonetics Corp shares are higher in after-market hours, nearing the top of their one-month trading range and above the 20-day moving average.

19 aug. 2026, 23:41 UTC

Haemonetics Corp shares declined after-market, retracing from earlier gains. The asset remains above its 20-day moving average and near the upper end of its one-month range.

18 aug. 2026, 23:42 UTC

Haemonetics Corp shares are trading lower in after-market hours, reflecting a decline from earlier highs, though remaining above the 20-day moving average.

17 aug. 2026, 20:06 UTC

Haemonetics Corp shares are lower today, reflecting broader market pressures amid a notable drop in U.S. retail sales for July.

14 aug. 2026, 19:51 UTC

Haemonetics Corp shares are higher today, supported by a positive trend in the Health Care Supplies sector and increased trading volume.

13 aug. 2026, 19:51 UTC

Haemonetics shares are declining amid rising jobless claims and flat Producer Price Index data, breaking a recent trend of higher daily closes.

12 aug. 2026, 20:01 UTC

Haemonetics Corp shares are higher today, supported by unusually high trading volume and a strong upward trajectory since Tuesday's close.

11 aug. 2026, 20:06 UTC

Haemonetics Corp shares are higher today, maintaining a position near the upper end of their one-month range despite a minor pullback earlier in the session.

10 aug. 2026, 19:46 UTC

Haemonetics Corp shares are declining amid broader market uncertainty following recent U.S. employment data, despite earlier gains during the session.

7 aug. 2026, 22:01 UTC

News

Haemonetics shares are lower in after-market trading despite Citigroup raising its price target to $92 and maintaining a Neutral rating.

6 aug. 2026, 21:01 UTC

Haemonetics Corp. shares are trading higher in after-market hours, remaining above the 20-day moving average and near the upper end of their one-month range.

5 aug. 2026, 19:31 UTC

Haemonetics Corp shares are lower today, breaking a trend of higher closes. The stock is experiencing unusually high trading volume amid no specific news.

4 aug. 2026, 21:01 UTC

Haemonetics Corp shares declined in after-market hours, despite broader market gains from positive U.S.-Iran negotiations and falling crude oil prices.

3 aug. 2026, 19:56 UTC

Haemonetics Corp shares are higher, reflecting broader market gains amid positive momentum in major tech stocks and easing geopolitical tensions.

31 iul. 2026, 20:04 UTC

Haemonetics Corp shares are higher, with no specific news identified. The broader market has also gained since Thursday's close, recovering from earlier losses.

30 iul. 2026, 19:48 UTC

Haemonetics Corp. shares are lower today, continuing a decline since Wednesday. The stock remains above its 20-day moving average despite recent downward movement.

29 iul. 2026, 21:21 UTC

Haemonetics Corp shares are lower in after-market trading, reflecting broader declines in the equity market and Health Care Supplies sector amid rising oil prices.

28 iul. 2026, 21:01 UTC

Haemonetics Corp shares are lower in after-market hours, following a broader market decline amid a significant drop in the Nikkei 225 Index.

27 iul. 2026, 22:51 UTC

Haemonetics Corp shares are higher in after-market trading, supported by falling crude oil prices and strong performance above the 20-day moving average.

24 iul. 2026, 20:31 UTC

Haemonetics Corp shares are lower in after-market hours, continuing a decline from Friday's close. No specific news was identified to explain the movement.

23 iul. 2026, 23:21 UTC

Haemonetics Corp shares are lower in after-market trading, continuing a decline that began after Thursday's close, reaching the midpoint of their one-month trading range.

22 iul. 2026, 20:13 UTC

Shares of Haemonetics Corp are trading higher in after-market hours, positioned above its 20-day moving average amid broader market volatility and rising crude oil prices.

20 iul. 2026, 18:46 UTC

Haemonetics Corp shares are higher today, continuing gains since Friday's close. The stock reached a session high earlier, though it has pulled back.

Comparație

Modificare preț

Haemonetics Corp Așteptări

Obiectiv de preț

By TipRanks

-5.55% jos

Prognoză pe 12 luni

Medie 102.38 USD -5.55%

Maxim 120 USD

Minim 84 USD

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHaemonetics Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

9 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 9 analiști care au acordat evaluări ale acțiunilor Haemonetics Corp - Dist în ultimele 3 luni.

Sentiment

By Acuity

326 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Haemonetics Corp

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.